U.S. Life Sciences Stock News

Red Cat Holdings (RCAT) saw its stock sink after a short seller report raised concerns about the size of its U.S. Army contract and questioned the company’s NDAA-compliance claims regarding its drone lineup. See our latest analysis for Red Cat Holdings. Red Cat’s share price has been on a rollercoaster, with a steep drop after the short seller report and dramatic bouncebacks throughout the year. Despite recent volatility, the company still boasts a remarkable 314% one-year total shareholder...

Avis Budget Group (CAR) is making moves to capture demand for higher-end travel with the European launch of Avis First, a concierge-style premium rental service at major airports. This strategic shift highlights the company’s growth ambitions in the evolving mobility market. See our latest analysis for Avis Budget Group. Avis Budget Group’s launch of its high-touch premium service comes after a year of dramatic swings for the stock, with recent events ranging from industry innovations to...

In the past week, an FDA adverse event report disclosed the death of a patient who had been treated with Ascendis Pharma’s hypoparathyroidism drug, Yorvipath, in a case complicated by multiple health issues and medications. This update has raised important questions about the safety profile of Yorvipath and the extent of possible regulatory scrutiny, even though the causal relationship remains undetermined. We will explore how heightened regulatory concerns around Yorvipath’s safety profile...

Amphastar Pharmaceuticals recently announced an exclusive 10-year distribution agreement with Nanjing Chengong Pharmaceutical to market its BAQSIMI nasal powder product across Mainland China, Taiwan, Hong Kong, and Macau. This deal expands Amphastar’s access to the Greater China region while highlighting a related party transaction reviewed and approved by independent company directors. We'll examine how this exclusive arrangement for BAQSIMI in Greater China could reshape Amphastar's...

Masco (MAS) shares lost 2% in the last trading session, drawing some attention from investors who are tracking the company’s recent performance. Over the past month, the stock dipped 3%, slightly lagging key benchmarks. See our latest analysis for Masco. While Masco's latest dip has drawn attention, the bigger picture shows momentum has cooled compared to last year. The share price return is down around 5% year-to-date, and total shareholder return for the past year sits at -14.7%. However,...

If you’re wondering whether to keep holding, buy more, or finally part ways with Genpact, you’re not alone. The stock has been on a bit of a roller coaster, inviting both cautious observers and value hunters to the table. Over the past year, Genpact’s price has ticked up a respectable 4.5%, despite a choppy ride that includes a 6.4% dip over the past month and an overall 8.1% slide year-to-date. While that kind of short-term volatility might spook some investors, it can also mean opportunity,...

OGE Energy (OGE) has seen its stock deliver a total return of 19% over the past year. The utility giant's performance has drawn some attention lately, and several investors are now weighing whether shares remain appealing as the company posts steady revenue and net income gains. See our latest analysis for OGE Energy. OGE Energy’s latest share price of $46.37 reflects a steady climb, with a year-to-date share price return of 12.3% and a one-year total shareholder return of 19.1%. This...

Uniti Group (UNIT) has drawn investor attention after unveiling an expansion of its wholesale business through a new partnership at MDC San Diego. The initiative boosts connectivity between the U.S. and Mexico and aims for stronger, more resilient cross-border fiber routes. See our latest analysis for Uniti Group. Uniti Group’s expansion at MDC San Diego has turned some heads, coming just as its share price staged a 6.2% rise over the past week. This is a rare bright spot in an otherwise...

If you’re thinking about whether Opera is a buy, sell, or just one to keep on your watchlist, you’re not alone. In the last week, the stock slipped by 3.2%, following a choppier month where it dropped 17.2%. That might make some investors uneasy, but if you zoom out, Opera’s story gets a lot more interesting. Despite the recent turbulence, the stock is still up a massive 356.5% over three years and 116.2% over the last five years. So, what’s driving these swings, and what could that mean for...

Danaher (NYSE:DHR) delivered strong third quarter results, with both sales and net income rising year-on-year. The company beat Wall Street’s revenue expectations, powered in part by steady demand for monoclonal antibody production and earlier than usual respiratory testing orders. See our latest analysis for Danaher. Danaher’s upbeat third quarter sealed a turn in sentiment, with the stock jumping nearly 6% in a single day and gaining over 20% in the past month alone. While the 1-year total...

Earlier this month, Kojo announced it had received Series C extension funding from Wesco International to integrate Wesco’s distribution network with Kojo’s AI-powered supply chain solutions for contractors. This partnership aims to automate material tracking, procurement, and delivery scheduling, offering contractors unprecedented real-time visibility and efficiency across project phases. Now, we'll explore how Wesco’s investment in AI-powered supply chain automation could reshape its...

Nebius Group (NasdaqGS:NBIS) is in the spotlight after announcing a major partnership with Microsoft to deliver dedicated GPU capacity, a deal worth up to $19.4 billion. The collaboration is fueling a global push to expand Nebius’s AI cloud infrastructure, with a planned ramp-up to 1 gigawatt capacity. See our latest analysis for Nebius Group. It has been a whirlwind year for Nebius Group, with the share price rocketing 284% since January and a 1-year total shareholder return approaching...

Affinity Bancshares (AFBI) reported a net profit margin of 23.7%, up from 18.3% a year ago, underscoring higher profitability relative to revenue. Earnings growth surged 34.5% year over year, materially above the company’s 5-year average of 3.4% per year and further highlighted by management as high quality. With margins improving and consistent profit gains, investors are likely to take note of both the stronger bottom line and the context of higher valuation multiples compared to industry...

Earlier this week, Cisco launched its AI-Powered Security Operations Centre (SOC) showcase at the Toronto Innovation Centre, offering Canadian organizations an interactive environment to experience advanced, AI-driven cybersecurity technologies in action. This initiative highlights the rising need for digital resilience, as Cisco’s own research shows the vast majority of Canadian organizations have faced AI-related cyber incidents in the past year while critical cybersecurity skill gaps...

Earlier this week, Elanco Animal Health Incorporated announced it has received Emergency Use Authorization from the U.S. FDA for Credelio to treat New World screwworm infestations in dogs, marking the first time such approval has been granted for this condition in dogs. This milestone positions Elanco as a key provider of an urgently needed treatment as New World screwworm cases were recently detected near the U.S.-Mexico border, addressing a growing animal and public health concern. We’ll...

Fluence Energy (FLNC) has caught the attention of investors recently, with its stock displaying notable movement over the past month. The company’s share price climbed 64% in that time, which has sparked fresh interest in the energy storage sector. See our latest analysis for Fluence Energy. This strong upward move comes after a choppy year, as Fluence Energy’s 1-year total shareholder return is still slightly negative, even with the stock’s impressive 120.8% share price gain over the last 90...

Banner (BANR) delivered a strong update for investors, reporting higher net income and net interest income for the third quarter. The company also raised its regular cash dividend by 4% to $0.50 per share, rewarding shareholders. See our latest analysis for Banner. Banner’s share price has seen a bit of turbulence this year, but after delivering solid earnings and a dividend boost, the mood is more optimistic. While the year-to-date share price return is still negative, shareholders are...

Recent analyst reports continue to back PROCEPT BioRobotics (PRCT), highlighting its innovation in surgical robotics and solid growth outlook. Even with financial challenges, analysts point to the company’s strategic focus and sector trends as positives. See our latest analysis for PROCEPT BioRobotics. PROCEPT BioRobotics' share price has seen some turbulence, with a sharp 90-day decline and a year-to-date share price return of -57.9% underscoring investor caution. Still, the company’s story...

Howmet Aerospace recently announced that Ken Giacobbe, its Executive Vice President and Chief Financial Officer, will retire on December 31, 2025, after 21 years of service, with Patrick Winterlich, formerly of Hexcel Corporation, set to assume the CFO role on December 1, 2025. This leadership transition brings a seasoned finance executive into Howmet at a time when the company faces important growth and operational opportunities in the aerospace sector. We will examine how the appointment...

Morgan Stanley recently reported third quarter 2025 earnings that surpassed Wall Street expectations, with net income rising to US$4.61 billion compared to US$3.19 billion a year earlier, driven by strong performance in capital markets and wealth management. Management highlighted renewed client activity, record client assets, and increased investment banking engagement, signaling broad-based growth across its core businesses. We'll examine how this robust earnings report and record client...

Bullish momentum is building around Churchill Capital Corp X (CCCX) as options traders pile into call contracts. Volumes have doubled the norm and implied volatility is spiking. The extremely low Put/Call Ratio suggests that optimism is widespread. See our latest analysis for Churchill Capital Corp X. After a quiet start to the year, Churchill Capital Corp X’s share price has climbed significantly in recent weeks, notching a 51.8% gain over the past month and doubling since the beginning of...

Recent reports highlight that German American Bancorp experienced strong net interest income growth along with an optimistic outlook for the next year. This improvement in a core profitability metric could signal further operational momentum for the bank heading into 2026. We'll explore how robust net interest income growth is shaping German American Bancorp's investment narrative and future prospects. The end of cancer? These 27 emerging AI stocks are developing tech that will allow early...

In October 2025, Appian (Nasdaq: APPN) was named a Leader in the 2025 Gartner Magic Quadrant for Business Orchestration and Automation Technologies, recognizing its unified AI process automation platform. This distinction underlines a growing industry move toward integrated automation solutions that blend low-code, robotic process automation, and complex workflow unification. We'll examine how Gartner's Leader recognition could strengthen Appian's industry credibility and support its...

Microchip Technology (MCHP) has caught the market’s eye lately, thanks to its announcements around next-generation Switchtec Gen 6 PCIe Switches and SkyWire time synchronization tech. These launches stand out even as broader semiconductor sentiment turns cautious. See our latest analysis for Microchip Technology. After rolling out its Gen 6 PCIe and SkyWire timing technologies, Microchip Technology has been caught up in broader sector turbulence. Recent total shareholder return over the past...